Publications by authors named "Barbara Goff"

Claim this Profile
A
A Call to Action From the American Gynecological & Obstetrical Society.
Ronald D Alvarez, Marcelle I Cedars, Barbara A Goff, Christos Coutifaris

Obstet Gynecol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chemotherapy provider specialty on outcomes in ovarian cancer.
Joyce Y Wang, Elise J Simons, Aleksei Dingel, Mindy M Pike, Lucas Chen, Barbara A Goff

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire.
Eric D Helm, Cam Nguyen, Stephen Rotholz, Saketh R Guntupalli, Barbara A Goff

Gynecol Oncol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access.
Ann Oluloro, Elizabeth M Swisher, Heidi J Gray, Barbara Goff, Kemi M Doll

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Framework for Building Surgical Competence in the Practice of Gynecology: A Discussion From the 2024 American Gynecological & Obstetrical Society Annual Meeting.
Ronald D Alvarez, Warner K Huh, AnnaMarie Connolly, Amy E Young, Meredith J Alston, Barbara A Goff

Obstet Gynecol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer.
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R Gwin, Jessica L Reichow, Barbara A Goff

Gynecol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions.
Julia M Dexter, Lindsay W Brubaker, Benjamin G Bitler, Barbara A Goff, Usha Menon

Gynecol Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidden in plain sight. Is there time to look?
Barbara A Goff

Gynecol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life, patient-centred communication and self-efficacy in ovarian cancer: a mediation analysis.
Rachel A Pozzar, Niya Xiong, Emanuele Mazzola, Alexi A Wright, Barbara A Goff

BMJ Support Palliat Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilevel Determinants of Palliative Care Referral in Women With Advanced Ovarian Cancer: A Scoping Review.
Susie Cho, Barbara A Goff, Donna L Berry

J Pain Symptom Manage· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scholarly activity following National Institutes of Health Women's Reproductive Health Research K12 training-a cohort study.
Erin E McCoy, Ronit Katz, Diana K N Louden, Emiko Oshima, Amy Murtha, Barbara A Goff

Am J Obstet Gynecol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing.
Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger, Barbara A Goff

NPJ Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros, Barbara A Goff

Eur J Gynaecol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does patient-centered communication in ovarian cancer care enhance patient well-being? A mixed methods study.
Rachel A Pozzar, Niya Xiong, Fangxin Hong, Alexi A Wright, Barbara A Goff

Gynecol Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usability and acceptability of the electronic self-assessment and care (eSAC) program in advanced ovarian cancer: A mixed methods study.
Mihkai Wickline, Seth Wolpin, Susie Cho, Holly Tomashek, Tanya Louca, Barbara Goff

Gynecol Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine lavage identifies cancer mutations and increased somatic mutation burden in individuals with ovarian cancer.
Talayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R Radke, Barbara A Goff

Cancer Res Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promotion of gender equity in obstetrics and gynecology: principles and practices for academic leaders.
Linda Brubaker, Erica Marsh, Marcelle I Cedars, Dee Fenner, Amy Murtha, Barbara Goff

Am J Obstet Gynecol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Is Not So Silent.
Barbara A Goff

Obstet Gynecol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States.
Soledad Jorge, Barbara A Goff, Heidi J Gray, Daniel A Enquobahrie, Kemi M Doll

JCO Oncol Pract· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancer.
Rachel A Pozzar, Niya Xiong, Fangxin Hong, Alexi A Wright, Barbara A Goff

Gynecol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod treatment of vulvar melanoma in situ invading the urethra.
Esther Fuchs, Anisha Khanijow, Rochelle L Garcia, Barbara A Goff

Gynecol Oncol Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Barbara A Goff

J Immunother Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Ronald D Alvarez, Barbara A Goff, David Chelmow, Todd R Griffin, Errol R Norwitz

Am J Obstet Gynecol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer.
Goldie Y L Lui, Reid Shaw, Franz X Schaub, Isabella N Stork, Kay E Gurley, Barbara A Goff

EBioMedicine· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement.
Ronald D Alvarez, Barbara A Goff, David Chelmow, Todd R Griffin, Errol R Norwitz

Am J Obstet Gynecol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis